Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications

Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications

Dry powder inhaler (DPI) is a device used to deliver a drug in dry powder form to the lungs. A wide range of DPI products is currently available, with the choice of DPI device largely depending on the dose, dosing frequency and powder properties of formulations. Computational fluid dynamics (CFD), t...

Full description

Bibliographic Details
Main Authors:	Zhanying Zheng, Sharon Shui Yee Leung, Raghvendra Gupta
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Pharmaceutics
Subjects:	dry powder inhalers (DPI) computational modelling computational fluid dynamics (CFD) discrete element methods (DEM) pulmonary drug delivery inhalation therapy
Online Access:	https://www.mdpi.com/1999-4923/13/2/189

Similar Items

Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery
by: Mehdi Hassanpour Aghdam, et al.
Published: (2016-03-01)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Development of an Innovative, Carrier-Based Dry Powder Inhalation Formulation Containing Spray-Dried Meloxicam Potassium to Improve the In Vitro and In Silico Aerodynamic Properties
by: Edit Benke, et al.
Published: (2020-06-01)

Three-dimensional DEM–CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers
by: Jiecheng Yang, et al.
Published: (2014-02-01)

Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
by: Styliani Xiroudaki, et al.
Published: (2021-09-01)

The Use of Video Instructions in Patient Education Promoting Correct Technique for Dry Powder Inhalers: An Investigation on Inhaler-Naïve Individuals
by: Sofia von Schantz, et al.
Published: (2018-09-01)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01)

Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery
by: Satu Lakio, et al.
Published: (2015-12-01)

Lactose Engineering for Better Performance in Dry Powder Inhalers
by: Yahya Rahimpour, et al.
Published: (2012-08-01)

The Use of a Three-Fluid Atomising Nozzle in the Production of Spray-Dried Theophylline/Salbutamol Sulphate Powders Intended for Pulmonary Delivery
by: Stefano Focaroli, et al.
Published: (2020-11-01)

Impact of selected construction elements of capsule-based dry powder inhalers on the manner of drug delivery to the lungs
by: Marcin Odziomek, et al.
Published: (2016-12-01)

Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In Vitro<i>–</i>In Silico Approach
by: Joana T. Pinto, et al.
Published: (2021-02-01)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
by: Tânia Marante, et al.
Published: (2020-10-01)

Physicochemical and Aerosolization Assessment of Inhalable Spray Dried Fluconazole Powder
by: Hamed Hamishehkar, et al.
Published: (2018-09-01)

Studies on the spray dried lactose as carrier for dry powder inhalation
by: Linna Wu, et al.
Published: (2014-12-01)

Practical, regulatory and clinical considerations for development of inhalation drug products
by: Shuguang Hou, et al.
Published: (2015-12-01)

Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance
by: Darbà J, et al.
Published: (2016-02-01)

Recent advances in capsule-based dry powder inhaler technology
by: Federico Lavorini, et al.
Published: (2017-05-01)

Development of High Efficiency Dry Powder Inhalers for Use with Spray Dried Formulations
by: Farkas, Dale
Published: (2017)

Patients’ usability of seven most used dry-powder inhalers in COPD
by: Roberto W. Dal Negro, et al.
Published: (2019-09-01)

Acute cardiopulmonary repercussions in the correct use of the dry-powder inhalers
by: Bruno Martinelli, et al.
Published: (2016-02-01)

Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with <span style="font-variant: small-caps">L</span>-Leucine or Trileucine
by: Imco Sibum, et al.
Published: (2019-12-01)

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
by: Federico Lavorini
Published: (2019-06-01)

Development of dry powder formulations of proteins for inhalation
by: Depreter, Flore
Published: (2012)

Investigations to identify the influence of the inhalation manoeuvre on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers: Studies to identify the influence of inhalation flow, inhalation volume and the number of inhalations per dose on the ex-vivo dose emission and the in-vitro aerodynamic dose emission characteristics of dry powder inhalers.
by: Ibn Yakubu, Sani
Published: (2011)

Spray Drying for the Preparation of Nanoparticle-Based Drug Formulations as Dry Powders for Inhalation
by: Maria Malamatari, et al.
Published: (2020-07-01)

Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01)

Development and Evaluation of Paclitaxel and Curcumin Dry Powder for Inhalation Lung Cancer Treatment
by: Wing-Hin Lee, et al.
Published: (2021-12-01)

Evaluation of cariogenic potential of dry powder inhalers: A case-control study
by: Navneet Godara, et al.
Published: (2013-01-01)

Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
by: Jaleh Varshosaz, et al.
Published: (2017-01-01)

Dispensing Guideline of Dry Powder Inhaler for Asthmatic and Chronic Obstructive Pulmonary Disease Patients at Out-Patient Dispensing Department
by: Karnchanok Maliphan, et al.
Published: (2012-10-01)

Dry Powders Inhalers (DPI) obtidos a partir de nanocápsulas de núcleo lipídico contendo budesonida : caracterização, avaliação in vivo em modelo animal de asma e da toxicidade in vitro em cultura celular
by: Ortiz, Manoel
Published: (2017)

Dry Powders Inhalers (DPI) obtidos a partir de nanocápsulas de núcleo lipídico contendo budesonida : caracterização, avaliação in vivo em modelo animal de asma e da toxicidade in vitro em cultura celular
by: Ortiz, Manoel
Published: (2017)

Dry Powders Inhalers (DPI) obtidos a partir de nanocápsulas de núcleo lipídico contendo budesonida : caracterização, avaliação in vivo em modelo animal de asma e da toxicidade in vitro em cultura celular
by: Ortiz, Manoel
Published: (2017)

Développement et évaluation de formulations lipidiques à poudre sèche pour inhalation
by: Sebti, Thami
Published: (2006)

Preparation and Characterization of Celecoxib Agglomerated Nanocrystals and Dry Powder Inhalation Formulations to Improve its Aerosolization Performance
by: Sepideh Mardani 1, Maryam Maghsoodi 2 * , Saeed Ghanbarzadeh 3,4, Ali Nokhodchi 5, Shadi Yaqoubi 6, Hamed Hamishehkar 7 *
Published: (2017-12-01)

Assessment of Patient’s Inhalation Technique in Songklanagarind Hospital: Proportion of Correct Inhaler Technique and Influenced Factors
by: Warangkana Keeratichananont, et al.
Published: (2012-08-01)

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
by: Li Ding, et al.
Published: (2021-08-01)

Assessment of asthmatic child inhalation device technique
by: Pedro Tiago Pinto, et al.
Published: (2018-10-01)

Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery
by: A. J. Mali, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_ivsm8rvhro90b4fh6faugg7k6g